Dose rounding of trastuzumab deruxtecan in chinese patients: cost savings and safety outcomes in real-world study - Poll - MDSpire

Dose rounding of trastuzumab deruxtecan in chinese patients: cost savings and safety outcomes in real-world study

  • By

  • Haochun Tang

  • Ziying Li

  • Ziyuan Zhou

  • Lingzhi Ren

  • Chengsheng Xie

  • Jun Meng

  • Guohui Li

  • June 15, 2026

  • 0 min

Share

Original Source(s)

Dose rounding of trastuzumab deruxtecan in chinese patients: cost savings and safety outcomes in real-world study

  • by Haochun Tang, Ziying Li, Ziyuan Zhou, Lingzhi Ren, Chengsheng Xie, Jun Meng, Guohui Li

  • June 15, 2026

Related Content

Vaginal microbiota and genitourinary syndrome of menopause in premenopausal breast cancer patients receiving endocrine therapy: a longitudinal cohort study protocol

Pretreatment cardiometabolic risk in newly diagnosed breast cancer: a molecular subtype analysis

Explainable AI in breast cancer ultrasound imaging: current developments and challenges